Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT03518112 · TERMINATED
Trial details
- NCT number
- NCT03518112
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2021-05-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.